Literature DB >> 22968374

Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls.

L K Vigsnæs1, J Brynskov, C Steenholdt, A Wilcks, T R Licht.   

Abstract

Detailed knowledge about the composition of the intestinal microbiota may be critical to unravel the pathogenesis of ulcerative colitis (UC), a human chronic inflammatory bowel disease, since the intestinal microbes are expected to influence some of the key mechanisms involved in the inflammatory process of the gut mucosa. The aim of this study was to investigate the faecal microbiota in patients either with UC in remission (n=6) or with active disease (n=6), and in healthy controls (n=6). The composition of Gram-negative bacteria and Gram-positive bacteria was examined. Antigenic structures of Gram-negative bacteria such as lipopolysaccharides have been related to the inflammatory responses and pathogenesis of inflammatory bowel disease. Dice cluster analysis and principal component analysis of faecal microbiota profiles obtained by denaturing gradient gel electrophoresis and quantitative PCR, respectively, revealed that the composition of faecal bacteria from UC patients with active disease differed from the healthy controls and that this difference should be ascribed to Gram-negative bacteria. The analysis did not show any clear grouping of UC patients in remission. Even with the relatively low number of subjects in each group, we were able to detect a statistically significant underrepresentation of Lactobacillus spp. and Akkermansia muciniphila in UC patients with clinically active disease compared to the healthy controls. In line with previous communications, we have shown that the microbiota in UC patients with active disease differ from that in healthy controls. Our findings indicate that alterations in the composition of the Gram-negative bacterial population, as well as reduced numbers of lactobacilli and A. muciniphila may play a role in UC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968374     DOI: 10.3920/BM2012.0018

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  36 in total

Review 1.  The first 1000 cultured species of the human gastrointestinal microbiota.

Authors:  Mirjana Rajilić-Stojanović; Willem M de Vos
Journal:  FEMS Microbiol Rev       Date:  2014-06-27       Impact factor: 16.408

2.  Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.

Authors:  Jose U Scher; Carles Ubeda; Alejandro Artacho; Mukundan Attur; Sandrine Isaac; Soumya M Reddy; Shoshana Marmon; Andrea Neimann; Samuel Brusca; Tejas Patel; Julia Manasson; Eric G Pamer; Dan R Littman; Steven B Abramson
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

3.  Triggering Akkermansia with dietary polyphenols: A new weapon to combat the metabolic syndrome?

Authors:  Fernando F Anhê; Geneviève Pilon; Denis Roy; Yves Desjardins; Emile Levy; André Marette
Journal:  Gut Microbes       Date:  2016

4.  Crystal structure of monomeric Amuc_1100 from Akkermansia muciniphila.

Authors:  Luqiu Mou; Xi Peng; Yan Chen; Qingjie Xiao; Huijuan Liao; Mingfeng Liu; Li Guo; Yang Liu; Xiaohu Zhang; Dong Deng
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-04-01       Impact factor: 1.056

5.  Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.

Authors:  Lien Van den Bossche; Pieter Hindryckx; Lindsey Devisscher; Sarah Devriese; Sophie Van Welden; Tom Holvoet; Ramiro Vilchez-Vargas; Marius Vital; Dietmar H Pieper; Julie Vanden Bussche; Lynn Vanhaecke; Tom Van de Wiele; Martine De Vos; Debby Laukens
Journal:  Appl Environ Microbiol       Date:  2017-03-17       Impact factor: 4.792

6.  Two-carbon folate cycle of commensal Lactobacillus reuteri 6475 gives rise to immunomodulatory ethionine, a source for histone ethylation.

Authors:  Daniel Röth; Abby J Chiang; Weidong Hu; Gabriel B Gugiu; Christina N Morra; James Versalovic; Markus Kalkum
Journal:  FASEB J       Date:  2018-11-19       Impact factor: 5.191

Review 7.  Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.

Authors:  M Giza; D Koftori; L Chen; P Bowness
Journal:  Clin Exp Immunol       Date:  2017-10-06       Impact factor: 4.330

Review 8.  Ulcerative colitis as a polymicrobial infection characterized by sustained broken mucus barrier.

Authors:  Shui-Jiao Chen; Xiao-Wei Liu; Jian-Ping Liu; Xi-Yan Yang; Fang-Gen Lu
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

9.  Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.

Authors:  Fatouma Salem; Nadège Kindt; Julian R Marchesi; Patrick Netter; Anthony Lopez; Tunay Kokten; Silvio Danese; Jean-Yves Jouzeau; Laurent Peyrin-Biroulet; David Moulin
Journal:  United European Gastroenterol J       Date:  2019-08-01       Impact factor: 4.623

10.  Composition and function of the pediatric colonic mucosal microbiome in untreated patients with ulcerative colitis.

Authors:  Rajesh Shah; Julia L Cope; Dorottya Nagy-Szakal; Scot Dowd; James Versalovic; Emily B Hollister; Richard Kellermayer
Journal:  Gut Microbes       Date:  2016-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.